drugset / Trial / NCT03506256

Noroxin Efficacy and Safety Trial

NCT03506256

Phase 4 Unknown 1000 enrolled OBS Pakistan
NaSingle-groupOpen-labelTreatment

Summary

To determine the efficacy and safety of Norfloxacin (Noroxin)

Timeline

Start
2018-05-10
Primary completion
2018-06-10
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Norfloxacin Small molecule 400 mg Oral